Medical Marijuana, Inc. (MJNA)

The Medical Marijuana Inc. (MJNA) team is made up of a diverse group of highly skilled professionals in their respected fields. Each individual who makes up the corporate structure of MJNA plays an integral part of the company's day to day operation and overall success. MJNA believes for a company to not merely succeed but thrive in any economic and political environment you must first have the right people on the team, make sure they are in the right position, and allow them to operate with integrity and an entrepreneurial spirit.

The MJNA executive team work with industry and world authorities on cannabinoid based science and technologies to source, evaluate, acquire and develop value added companies and products. Each of the entities that make Medical Marijuana Inc.'s structure has a clearly defined purpose as it relates to an individual market, consumer or partner need. By utilizing these different facets, MJNA is able to provide an unparalleled platform of businesses that are unique among industry competitors. The professionals at MJNA are dedicated to "keeping it simple". In an industry that has ever changing economic, political and scientific climate, its MJNA's team's ability to do just that that sets it apart.

Board of Directors

Michelle Sides
Chairman

David Darlington
Vice Chairman

Director

Gideon Wolf
Director

David Farrand
Director

Tripp Keber
Director 

Executive Management

Robert Plomgren
Chief Financial Officer

Michelle Sides, Esq.
Chief Operating Officer
Chairman 

David Darlington
President, PhytoSHERE Systems 
Vice Chairman

Tripp Keber
President, RDH Licensing

Babak R. Ghalili
Medical Director

Dr. Philip A. Van Damme
Director, Canchew Biotechnologies

Dr. George E. Anastassov
Director, Canchew Biotechnologies 

Lekhram Changoer
Director, Canchew Biotechnologies   

Advisory Committees

Risk Management Committee

Robert Plomgren

Vernon Darrimon

Agricultural Committee

Gideon Wolf

David Farrand

Medical Committe

Babak R. Ghalili

Dr. Philip A. Van Damme

Dr. George E. Anastassov

Lekhram Changoer 

Dixie Elixirs and Edibles ("DEE")family of products consist of six unique and carefully formulated product lines of well over forty medicinal hemp infused products including medicated beverages and tonics, hemp capsules, medicated lozenges and edibles, as well as a full line of topicals and salves as part of the Dixie botanicals line of products which was recently featured on National Geographic's series American Weed.As one of the World's most recognized medicinal hemp brands, Dixie is currently in over 400 retail locations in Colorado alone and expanding rapidly. Dixie focuses on the development of innovated medically and socially acceptable delivery methods. Dixie is licensing their formulas, delivery methods and technology to other socially conscious companies in an effort to rapidly expand their distribution base.

PhytoSPHERE Systems("PS") is the worlds leading cannabinoid based biotechnology company that builds and develops technologies and deploys them in state of the art facilities that are self contained highly efficient, safe, pollutant free cultivation, extraction and production facilities for the pharmaceutical and nutraceutical industries.PhytoSPHERE's highly efficient growth, packaging and extraction technologies provides clients a compact, safe, pollutant-free facility which will allow it to:
Greatly increase plant production through yields that significantly exceed traditional methods.
Completely control the cultivation environment resulting in superior plant growth, uniform strain purity, quality crop production, and year-round production potential.
Reduce per-unit costs compared to traditional methods by eliminating the use of pesticides, fungicides and herbicides.
Produce Pharmaceutical grade extracts.
Establish antibacterial environments and packaging systems.
Control post production processing with proprietary standardization methods.
PhytoSPHERE's three core technologies consist of:
A module that places rows of plants perpendicular to an interior light source, which helps accelerate the growth rate and efficiency of the particular plant that is being cultivated.
Computer operated sprayers ensure even distribution of nutrient feeding solutions to the crops resulting in an abundance of plants with strong, compact, and multi-directional growth. This state-of-the-art technology is fully contained, meaning crops can be grown year-round in any location using precise combinations of light, water, and nutrients to maximize production.
A proprietary antibacterial product clipping, curing and packaging system, allowing for a truly pharmaceutical grade method of cultivation.
An extraction and production process for cannabinoid based compounds derived from the cannabis plant, which uses standardized processes and technology to create the world's leading pharmaceutical grade extracts. 

The History of Hemp as an industrial and medicinal product dates to the beginning of recorded history. It has been estimated that marijuana in the United States alone is a $110 billion market and the medical market makes up nearly $1.7 billion. Industrial hemp with its many uses such as fuel, food, textiles, building materials, and bioremediation is nearly impossible to quantify. Today the industry is fragmented and grossly underutilized, and under developed for a number of reasons that stretch date back hundreds of years. Mostly because of a stigma created from one species of the Cannabis plant that has a significantly higher amount of tetrahydrocannabinol (THC) and can be used as a recreational drug.

We invite you to read our Research and Development page as well as by clicking on the links below. If there is any relevant information that you feel we should share with our readers or with Medical Marijuana Inc., please email us at  Web@MedicalMarijuanaInc.com and we will be sure to make additional prudent information available to our shareholders, partners and the public.